grepafloxacin   Click here for help

GtoPdb Ligand ID: 10818

Synonyms: OPC 17116 | OPC-17116 | OPC17116 | Raxar®
Approved drug
grepafloxacin is an approved drug
Compound class: Synthetic organic
Comment: Grepafloxacin is a quinolone antibacterial [1-2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 3
Topological polar surface area 74.57
Molecular weight 359.16
XLogP 4.53
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1NCCN(C1)c1cc2c(c(c1F)C)c(=O)c(cn2C1CC1)C(=O)O
Isomeric SMILES CC1NCCN(C1)c1cc2c(c(c1F)C)c(=O)c(cn2C1CC1)C(=O)O
InChI InChI=1S/C19H22FN3O3/c1-10-8-22(6-5-21-10)15-7-14-16(11(2)17(15)20)18(24)13(19(25)26)9-23(14)12-3-4-12/h7,9-10,12,21H,3-6,8H2,1-2H3,(H,25,26)
InChI Key AIJTTZAVMXIJGM-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Grepafloxacin was withdrawn from markets worldwide in 1999 because a serious side effect was elongation of the QT interval. Prior to withdrawl it had been used to treat exacerbations of chronic bronchitis caused by susceptible bacteria (e.g. Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis), community-acquired pneumonia (including those, in addition to the above pathogens, caused by Mycoplasma pneumoniae), gonorrhea and non-gonococcal urethritis and cervicitis (caused by Chlamydia trachomatis or Ureaplasma urealyticum for example).